Skip to main content
Aplab Ltd. logo

Aplab Ltd. — Investor Relations & Filings

Ticker · 890217 ISIN · IN9273A01047 LEI · 3358005DVRNWJLJH2Y24 BSE.NS Manufacturing
Open in API
Filings indexed 352 across all filing types
Latest filing 2022-04-06 Regulatory Filings
Country IN India
Listing BSE.NS 890217

About Aplab Ltd.

https://www.aplab.com

Aplab Ltd. specializes in the design, manufacture, and marketing of professional electronic equipment. The product portfolio includes test and measurement instruments, power conversion and control systems, uninterruptible power supplies (UPS), and solar power solutions. The company also provides specialized hardware for banking and retail automation, including automated teller machines and self-service kiosks. Serving sectors such as defense, telecommunications, education, and industrial manufacturing, the organization focuses on research and development to deliver high-precision laboratory instruments and robust power electronics. Its solutions encompass smart card-based systems and specialized power supplies for critical infrastructure, emphasizing technical reliability and engineering excellence.

Recent filings

Filing Released Lang Actions
Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the quarter ended 31st March, 2022
Regulatory Filings
2022-04-06 English
Compliances Certificate received from Registrars under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st March, 2022.
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming compliance for the quarter ended 31st March 2022. It is a confirmation certificate issued by the Registrar and Share Transfer Agents, not a financial report or detailed filing. The document is short (2634 characters) and serves as a compliance confirmation rather than a report or announcement of financial results. It does not contain financial statements or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and miscellaneous regulatory documents.
2022-04-06 English
Closure of Trading Window for the approval of Audited Financial Results for the quarter and year ended 31st March, 2022
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the stock exchange (BSE Limited) informing about the closure of the trading window for insiders due to the upcoming declaration of audited financial results for the fiscal year ended March 31, 2022. It references SEBI regulations on insider trading and states the trading window closure period but does not contain any financial data, results, or detailed report content. The document is short (1425 characters) and serves as an announcement related to compliance and trading restrictions ahead of financial results disclosure. Therefore, it is neither the financial report itself nor a detailed management or audit report. It fits best as a Regulatory Filing (RNS) since it is a compliance-related announcement to the exchange without substantive financial data or report content.
2022-04-06 English
Approval of un-audited financial results for the quarter and nine months ended 31st December, 2021 and other matters
Regulatory Filings
2022-02-14 English
Outcome of Board Meeting held on 14th February, 2022 for un-audited financial results for the quarter and nine months ended 31st December, 2021 and other matters.
Regulatory Filings Classification · 95% confidence The document is a letter dated February 14, 2022, addressed to the stock exchange's corporate relationship department. It announces the outcome of a board meeting held on the same day, specifically the approval of unaudited financial results for the third quarter and nine months ended December 31, 2021. The document is short (1202 characters) and serves as an announcement of the approval of interim financial results rather than containing the full financial statements or detailed analysis. It also mentions the publication of an abstract of the results in newspapers, indicating this is a regulatory announcement of financial results rather than the full interim report itself. Therefore, this document fits best under the category of Interim / Quarterly Report (IR) as it relates to quarterly financial results, but since it does not contain the full report or detailed financial data, it is more accurately classified as a Regulatory Filing (RNS) announcing the outcome of the board meeting and approval of results.
2022-02-14 English
APLAB LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve the un-audited financial results for ....
Regulatory Filings Classification · 95% confidence The document is a letter notifying the stock exchange (BSE Limited) about the convening of a Board Meeting to take on record the Un-audited Financial Results for the third quarter and nine months ended 31st December 2021. It references the upcoming meeting date and the agenda to consider the financial results but does not contain the financial results themselves. The document length is short (1293 characters) and serves as an announcement rather than the actual financial report. According to the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such regulatory announcements that do not fit other specific categories.
2022-02-02 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.